News & Events

From 13 to 15 October 2015, “SIA PharmIdea” participated in the leading pharmaceutical exhibition “CPhI Worldwide 2015” in Madrid, Spain. During the exhibition PharmIdea met with its existing business partners, as well as introduced potential cooperation partners to its world class products and services. PharmIdea exhibition Stand placed in the Hall 7 under the number 7D101.

PharmIdea’s core competence is development, GMP manufacturing and international marketing of small batch size sterile products in vials, in both lyophilized and liquid forms. For sterile products company’s services also include contract manufacturing, technology development, validation, elaboration of specifications and test methods, stability studies as well as all other documentation development under request of client for process or product registration. Company owns licence for contract manufacturing of investigational medical products (IMP) for clinical trials.

Besides injectables, PharmIdea also offers contract development of active pharmaceutical ingredients (API), what includes also finding appropriate contract manufacturing partner for regular production of API, as well as Active Substance Master File development.

Products: Atosiban, Bortezomib, Caspofungin, Dexmedetomidin, Zoledronic acid.